Laurence de Schoulepnikoff
Chief Operating Officer at OSE IMMUNOTHERAPEUTICS
Network origin in Laurence de Schoulepnikoff first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 | |
Tridek-One Therapeutics SAS
 Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Swiss Healthcare Licensing Group
3
| Private Company | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Laurence de Schoulepnikoff via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| GUERBET | Medical Specialties | Comptroller/Controller/Auditor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Apave SA
 Apave SA Miscellaneous Commercial ServicesCommercial Services Apave SA specializes in tests for quality control. The company was founded in 1867 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
| THERADIAG | Medical Specialties | Director/Board Member Chairman | |
| Institut National Polytechnique de Grenoble | College/University | Undergraduate Degree | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree | |
Deloitte SAS
 Deloitte SAS Miscellaneous Commercial ServicesCommercial Services Deloitte SAS provides legal, accounting, auditing, and consulting services. It offers solutions in risk management, mergers and acquisitions, tax systems, audit and assurance, and human capital. The company was founded on January 16, 2001 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| European Vaccine Manufacturers | President | ||
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Founder Chief Operating Officer | |
| University of Lyon | College/University | Doctorate Degree Undergraduate Degree | |
| Strategic Ventures & Research, Inc. | Founder | ||
| Sanofi-Aventis Japan | Comptroller/Controller/Auditor | ||
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Établissement Français du Sang
 Établissement Français du Sang BiotechnologyHealth Technology Établissement Français du Sang collects, prepares, qualifies and distributes blood transfusion products. The company is headquartered in Saint-Denis, France. | Biotechnology | Chief Executive Officer | |
| Manchester Business School | College/University | Masters Business Admin Masters Business Admin | |
Mouvement des Entreprises de France
 Mouvement des Entreprises de France Miscellaneous Commercial ServicesCommercial Services Mouvement des Entreprises de France operates a network for entrepreneurs. The non-profit company is based in Paris, France. The CEO of the French company is Philippe Pascal Rene Gautier. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Ecole Supérieure De Commerce D'angers | College/University | Undergraduate Degree | |
| École des Hautes Études Commerciales du Nord | College/University | Undergraduate Degree | |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Medical Distributors | Corporate Officer/Principal | |
Germitec SA
 Germitec SA Medical SpecialtiesHealth Technology Germitec SA engages in the research, design, and marketing of medical hygiene systems. It develops Antigermix, which is used in disinfecting heat-sensitive medical instruments. The company was founded in 2005 and is headquartered in Ivry-sur-Seine, France. | Medical Specialties | Director/Board Member | |
Atlanpole Biotherapies
 Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Director/Board Member | |
| BioVision | Chairman | ||
| Myasterix | Director/Board Member | ||
| Fondation pour l’Université de Lyon | Chairman | ||
| Imperial College Business School | College/University | Masters Business Admin | |
| Louis Dreyfus Foundation | Director/Board Member | ||
| Aperana Consulting SAS | Chairman | ||
| Lariboisière Hospital | Corporate Officer/Principal | ||
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
| Aventis Pharma International SAS | Corporate Officer/Principal | ||
| Underground Charity Foundation | Chairman | ||
| Fondation Universite Grenoble Alpes | Director/Board Member | ||
| Institut Sup Biotech De Paris | College/University | Director/Board Member | |
| Ose Immunotherapeutics, Inc. | Chief Executive Officer | ||
Olgram SAS
 Olgram SAS Miscellaneous Commercial ServicesCommercial Services Olgram SAS provides scientific research and development services. The company is based in Brehan, France. The French company was founded by Hervé Balusson, Maryvonne Hiance, Karim Asehnoune, Pi Nyvall Collén, Pierre Rocheteau. Pierre Rocheteau has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
| Guerbet Imagem do Brasil Ltda. | Chief Executive Officer | ||
| Healthtech For Care | Chairman | ||
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Pharmaceuticals: Major | Founder | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistics
International
| France | 37 |
| United Kingdom | 4 |
| Netherlands | 4 |
| Belgium | 4 |
| United States | 3 |
Sectoral
| Health Technology | 17 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 2 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 106 |
| Corporate Officer/Principal | 59 |
| Chairman | 35 |
| Chief Executive Officer | 31 |
| Independent Dir/Board Member | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Eric Jean Marie Leire | 27 |
| Didier Hoch | 24 |
| Alexandre LeBeaut | 22 |
| Klaus Breiner | 16 |
| Dominique Costantini | 15 |
| Maryvonne Hiance | 15 |
| Elsy Boglioli Hofman | 14 |
| Erik van den Berg | 13 |
| Alain Huriez | 12 |
| Alexis Peyroles | 10 |
| Jean-Patrick Demonsang | 9 |
| Gérard Tobelem | 9 |
| Héloïse Deliquiet | 9 |
| Fraser Murray | 8 |
| Sarah Holland | 8 |
- Stock Market
- Insiders
- Laurence de Schoulepnikoff
- Company connections
